Executive Summary
A remarkable surge of 53 officer change disclosures under Item 5.02 occurred across diverse US companies on a single day (January 12, 2026), representing an unprecedented concentration that signals potential systemic boardroom turbulence, routine administrative batching, or undisclosed sector pressures rather than isolated events. Nearly all filings are neutral with low-to-medium risk and materiality (average ~3/10), but the uniform lack of specifics on positions, individuals, or change types (appointment vs. resignation) heightens opacity and uncertainty. Cumulative implications include broad governance watchfulness, particularly in healthcare/biotech, with limited immediate alpha but elevated monitoring priority for follow-on details revealing stability or instability.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from January 08, 2026.
Investment Signals(4)
- ▲
Extreme single-day volume of 53 officer changes across sectors indicates heightened leadership flux [BEARISH] - Broad US equity market
- ▲
Co-occurrence of Item 5.02 with Item 2.02/7.01 in ~25% of filings suggests potential positive financial catalysts amid changes [BULLISH] - Duolingo, Neogenomics, NetApp, Outset Medical
- ▲
Bearish sentiment tied to restructuring costs in biotech [BEARISH] - Lyra Therapeutics
- ▲
Higher materiality filings (5+/10) in growth sectors may signal proactive succession [BULLISH] - Neogenomics, NetApp, Zymeworks
Risk Flags(4)
- [SYSTEMIC RISK]▼
Uniform absence of critical details (positions, reasons, individuals) in all 53 filings amplifies governance uncertainty and potential hidden instability
- (MARKET-WIDE CONCERN)▼
Concentration of changes on one day raises flags for coordinated executive exits, performance pressures, or regulatory anomalies
- ▼
Bearish restructuring signals in biotech alongside officer churn [SECTOR RISK] - Lyra Therapeutics and peers
- ▼
Auditor changes paired with officer shifts in select firms hint at deeper operational distress [COMPANY-SPECIFIC] - GlobalTech Corp
Opportunities(4)
- (ALPHA OPPORTUNITY)◆
Healthcare/biotech concentration (~20 filings) offers alpha from digging into undisclosed exhibits for bargain succession plays
- (PORTFOLIO POSITION)◆
Large-cap names like Verizon, Moody's, Chipotle with neutral changes provide relative stability hedges amid small-cap churn
- (CATALYST PLAY)◆
Filings bundled with Reg FD (Item 7.01) or earnings previews may uncover positive leadership upgrades upon full review
- (EVENT-DRIVEN)◆
Mass disclosure wave could trigger oversold reactions in high-materiality names for contrarian longs
Sector Themes(3)
- ◆
Healthcare/biotech dominance (e.g., Thermo Fisher, Neogenomics, Lyra, Zimmer Biomet) with frequent financial co-disclosures signals sector-wide leadership refresh amid clinical/commercial pressures
- ◆
Tech/software firms (e.g., Gitlab, NetApp, Sonos) show routine changes often paired with Reg FD, indicating stable succession in high-growth areas
- ◆
Cross-sector pattern of Item 9.01 exhibits without details suggests standardized compensatory arrangements, potentially masking M&A or incentive realignments
Watch List(4)
- 👁
Lyra Therapeutics - Highest materiality (6/10) bearish with exit costs; monitor for restructuring fallout
- 👁
Neogenomics/NetApp/Zymeworks - Elevated materiality (5/10) with financial ties; track for positive succession reveals
- 👁
Healthcare cluster (Kyverna, Outset Medical, Inspire Medical) - Volume intensity vs. sparse details warrants exhibit review
- 👁
Large caps (Verizon, Moody's, Chipotle) - Gauge if single-day spike correlates with broader market governance trends
Filing Analyses(53)
12-01-2026
Thermo Fisher Scientific Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001140361-26-000871, Size: 310 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements. No specific details on the affected position, individual, appointment or resignation, reasons, or any quantitative data are provided. Sector is not specified.
12-01-2026
Sensus Healthcare, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001753926-26-000088, Size: 215 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data provided in the filing summary.
12-01-2026
Katapult Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0000950103-26-000342, Size: 253 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the key position affected, appointment or resignation, reasons, named individuals, or other impacts are provided. Sector is not specified.
12-01-2026
Twin Vee PowerCats, Co. filed a Form 8-K on January 12, 2026 (AccNo: 0001731122-26-000038, Size: 190 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Sector is not specified. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary.
12-01-2026
Duolingo, Inc. disclosed an Officer Change event via Form 8-K filed on 2026-01-12 (AccNo: 0001628280-26-001730, Size: 10 MB), covering Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, nature of change (appointment/resignation), reasons, or financial metrics are provided in the summary. Sector is not specified.
12-01-2026
WEX Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001140361-26-000891, Size: 1 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the summary. Sector is not specified.
12-01-2026
Lindsay Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009690, Size: 171 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, reasons for change, voting outcomes, or exhibits are provided. Sector is not specified.
12-01-2026
Trinseo PLC filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002698, Size: 256 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 includes financial statements and exhibits. No specific details on positions, names, reasons, or quantitative data provided in the filing summary.
12-01-2026
Henry Schein Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009725, Size: 596 KB), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), with Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for changes, or quantitative data are provided in the filing summary. Sector is not specified.
12-01-2026
Neogenomics Inc. filed an 8-K on January 12, 2026 (AccNo: 0001628280-26-001746, Size: 275 KB), disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). Event type is Officer Change from US SEC source. No specific details on the officer position, appointment/resignation, reasons, or financial metrics are provided.
12-01-2026
Lyra Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009772), disclosing costs associated with exit or disposal activities under Item 2.05, departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements under Item 5.02, and other events under Item 8.01. Event classified as Officer Change. No specific numerical values, names, reasons, or details provided in the summary.
12-01-2026
Kyverna Therapeutics, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009810, Size: 277 KB), disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). Specific details on the officer change, including position affected, appointment/resignation status, reasons, or any quantitative data, are NOT_DISCLOSED. No sector specified.
12-01-2026
MACOM Technology Solutions Holdings, Inc. disclosed an Officer Change via Form 8-K filed on January 12, 2026 (AccNo: 0001493594-26-000002, Size: 207 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason for change, or quantitative data are provided in the summary.
12-01-2026
Outset Medical, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009865, Size: 7 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), alongside Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or financial metrics are disclosed. All quantitative data such as transaction values, share counts, or percentages is NOT_DISCLOSED.
12-01-2026
Green Plains Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001309402-26-000009, Size: 289 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the available information. Sector is not specified.
12-01-2026
GitLab Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001653482-26-000009, Size: 121 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.
12-01-2026
Zimmer Biomet Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009895, size: 187 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change from US SEC source. Sector not specified.
12-01-2026
Forum Energy Technologies, Inc. disclosed an officer change via Form 8-K filed on January 12, 2026 (AccNo: 0001401257-26-000002, Size: 183 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or any quantitative data are provided in the available information. Sector is not specified.
12-01-2026
ZION OIL & GAS INC filed a Form 8-K on January 12, 2026 (AccNo: 0001437749-26-001070, Size: 144 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or compensation are provided.
12-01-2026
Flanigan's Enterprises Inc. disclosed an officer change via SEC Form 8-K filed on January 12, 2026 (AccNo: 0001174947-26-000032, Size: 187 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data such as compensation amounts are provided in the available information. Sector is not specified.
12-01-2026
Alexandria Real Estate Equities, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001104659-26-002862), disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
12-01-2026
RMR Group Inc. filed an 8-K on January 12, 2026 (AccNo: 0001104659-26-002868, Size: 192 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, appointment/resignation, reasons, or individuals are disclosed in the provided information. Sector is not specified.
12-01-2026
Ambow Education Holding Ltd. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003384, Size: 266 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, appointment/resignation, reasons, or compensation are disclosed.
12-01-2026
Medallion Financial Corp filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-010406), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position, reason for change, or quantitative data are provided in the filing summary.
12-01-2026
INTERGROUP CORP filed a Form 8-K on 2026-01-12 (AccNo: 0001493152-26-001843, Size: 208 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Event date is January 12, 2026. Sector not specified; no further details on positions, individuals, or reasons provided.
12-01-2026
First Bancorp, Inc /ME/ filed a Form 8-K on January 12, 2026 (AccNo: 0000765207-26-000003, size: 126 KB), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, individuals involved, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
12-01-2026
Sonos Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001314727-26-000004, Size: 180 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or quantitative data provided.
12-01-2026
NetApp, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010401, Size: 177 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, appointment or resignation status, reasons, named individuals, and any quantitative data are NOT_DISCLOSED. Sector is not specified.
12-01-2026
Shuttle Pharmaceuticals Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001861, Size: 249 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available filing summary. Sector is not specified.
12-01-2026
Verizon Communications Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010395, Size: 430 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or individuals are disclosed. Sector is not specified, and no quantitative financial data is mentioned.
12-01-2026
POOL CORP filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010379, Size: 380 KB), disclosing under Item 5.02 a matter involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer, position, reason for change, or any quantitative data are provided in the filing summary.
12-01-2026
CAVA GROUP, INC. filed a Form 8-K on January 12, 2026 (AccNo: 0001628280-26-001818, Size: 160 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.
12-01-2026
MASCO CORP /DE/ filed an 8-K on January 12, 2026 (AccNo: 0001213900-26-003396, Size: 188 KB), disclosing under Item 5.02 information regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the officer involved, reason for change, or any quantitative data are provided in the available summary. Sector is not specified.
12-01-2026
FIRST NORTHERN COMMUNITY BANCORP filed a Form 8-K on January 12, 2026 (AccNo: 0001114927-26-000002, Size: 357 KB), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are disclosed in the provided filing summary.
12-01-2026
Workhorse Group Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001628280-26-001835, Size: 136 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals involved, positions, reasons for change, or any numerical data are provided. Sector is not specified.
12-01-2026
Zymeworks Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010480, Size: 300 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer involved, position affected, reason for change, or any quantitative financial metrics are NOT_DISCLOSED. Sector is not specified.
12-01-2026
Chipotle Mexican Grill Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001058090-26-000002, Size: 174 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position, appointment/resignation, reasons, or compensation are provided in the summary. Sector not specified.
12-01-2026
RxSight, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010478, Size: 196 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or individuals involved are provided. No quantitative data, named people, or additional facts are disclosed in the summary.
12-01-2026
Artisan Partners Asset Management Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001517302-26-000003, Size: 242 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any quantitative data such as compensation or share counts are provided in the summary. Sector is not specified.
12-01-2026
Regions Financial Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001281761-26-000003, Size: 271 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, appointment/resignation status, reasons, or quantitative data are provided.
12-01-2026
Babcock & Wilcox Enterprises, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001104659-26-002884, Size: 247 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual names, appointment/resignation status, reasons, or compensation are disclosed in the provided information. Sector is not specified.
12-01-2026
Pelthos Therapeutics Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001753926-26-000094, Size: 6 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. No specific details on the affected officer, position, appointment/resignation, reasons, or compensation provided in the filing summary. Sector not specified.
12-01-2026
Galectin Therapeutics Inc. disclosed an officer change via Form 8-K filed on January 12, 2026 (AccNo: 0001140361-26-000994, Size: 151 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions, individuals, reasons, or compensation are provided in the available summary.
12-01-2026
Jamf Holding Corp. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002883, Size: 185 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer, position, appointment/departure, reasons, or compensation provided in the available summary. Sector not specified.
12-01-2026
USBC, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001654954-26-000275, Size: 142 KB), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on affected positions (e.g., CEO, CFO), appointment/resignation status, reasons, individuals involved, or quantitative data are provided in the summary. Sector is not specified.
12-01-2026
TrueBlue, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0000768899-26-000002, Size: 180 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation, reasons, or compensation provided. Sector not specified.
12-01-2026
GlobalTech Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001477932-26-000161, Size: 179 KB), disclosing changes in certifying accountant (Item 4.01), departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific names, positions, reasons, quantitative data, or further details provided. Sector not specified.
12-01-2026
Moody's Corp /DE/ filed an 8-K on January 12, 2026 (AccNo: 0001059556-26-000004, Size: 4 MB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Event classified as Officer Change from US SEC source.
12-01-2026
Grace Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001140361-26-000995, Size: 337 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the available information.
12-01-2026
Inspire Medical Systems, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001609550-26-000006, Size: 5 MB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer involved, position affected, reason for change, or any quantitative data such as transaction values, share counts, or financial metrics are disclosed. Sector is not specified.
12-01-2026
ASP Isotopes Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001477932-26-000162, Size: 150 KB), disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer, position, appointment/resignation, reasons, or impacts are disclosed.
12-01-2026
Yum China Holdings, Inc. disclosed an officer change event via SEC Form 8-K filed on January 12, 2026 (AccNo: 0001193125-26-010568, Size: 204 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, nature of change, reasons, or quantitative data are provided in the available information.
12-01-2026
DIRTT Environmental Solutions Ltd filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010658, Size: 194 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary.
Get daily alerts with 4 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 53 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings